메뉴 건너뛰기




Volumn 9, Issue , 2015, Pages 1049-1056

Potential role of lampalizumab for treatment of geographic atrophy

Author keywords

Age related macular degeneration; AMD; Complement inhibition

Indexed keywords

RETRACTED ARTICLE; REVIEW;

EID: 84934756694     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S59725     Document Type: Review
Times cited : (24)

References (32)
  • 1
    • 1842530296 scopus 로고    scopus 로고
    • Causes and prevalence of visual impairment among adults in the United States
    • Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477-485.
    • (2004) Arch Ophthalmol. , vol.122 , Issue.4 , pp. 477-485
    • Congdon, N.1    O'Colmain, B.2    Klaver, C.C.3
  • 2
    • 0242526930 scopus 로고    scopus 로고
    • Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11
    • Bressler NM, Bressler SB, Congdon NG, et al; Age-Related Eye Disease Study Research Group. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol. 2003;121(11):1621-1624.
    • (2003) Arch Ophthalmol. , vol.121 , Issue.11 , pp. 1621-1624
    • Bressler, N.M.1    Bressler, S.B.2    Congdon, N.G.3
  • 3
    • 70349255600 scopus 로고    scopus 로고
    • Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26
    • Lindblad AS, Lloyd PC, Clemons TE, et al; Age-Related Eye Disease Study Research Group. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol. 2009;127(9):1168-1174.
    • (2009) Arch Ophthalmol. , vol.127 , Issue.9 , pp. 1168-1174
    • Lindblad, A.S.1    Lloyd, P.C.2    Clemons, T.E.3
  • 4
    • 33749451356 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    • Brown DM, Kaiser PK, Michels M, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432-1444.
    • (2006) N Engl J Med. , vol.355 , Issue.14 , pp. 1432-1444
    • Brown, D.M.1    Kaiser, P.K.2    Michels, M.3
  • 5
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-1431.
    • (2006) N Engl J Med. , vol.355 , Issue.14 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 6
    • 38349172455 scopus 로고    scopus 로고
    • Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1
    • Regillo CD, Brown DM, Abraham P, et al. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol. 2008;145(2):239-248.
    • (2008) Am J Ophthalmol. , vol.145 , Issue.2 , pp. 239-248
    • Regillo, C.D.1    Brown, D.M.2    Abraham, P.3
  • 8
    • 0034800655 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
    • Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
    • (2001) Arch Ophthalmol. , vol.119 , Issue.10 , pp. 1417-1436
  • 9
    • 84868196171 scopus 로고    scopus 로고
    • The Age-Related Eye Disease Study 2 (AREDS2): Study design and baseline characteristics (AREDS2 report number 1)
    • Chew EY, Clemons T, SanGiovanni JP, et al; AREDS2 Research Group. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012;119(11):2282-2289.
    • (2012) Ophthalmology. , vol.119 , Issue.11 , pp. 2282-2289
    • Chew, E.Y.1    Clemons, T.2    SanGiovanni, J.P.3
  • 10
    • 0031451121 scopus 로고    scopus 로고
    • Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity
    • Sunness JS, Rubin GS, Applegate CA, et al. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology. 1997;104(10):1677-1691.
    • (1997) Ophthalmology. , vol.104 , Issue.10 , pp. 1677-1691
    • Sunness, J.S.1    Rubin, G.S.2    Applegate, C.A.3
  • 11
    • 29244470800 scopus 로고    scopus 로고
    • Long-term follow-up of fixation patterns in eyes with central scotomas from geographic atrophy that is associated with age-related macular degeneration
    • Sunness JS, Applegate CA. Long-term follow-up of fixation patterns in eyes with central scotomas from geographic atrophy that is associated with age-related macular degeneration. Am J Ophthalmol. 2005;140(6):1085-1093.
    • (2005) Am J Ophthalmol. , vol.140 , Issue.6 , pp. 1085-1093
    • Sunness, J.S.1    Applegate, C.A.2
  • 12
    • 33846507899 scopus 로고    scopus 로고
    • The long-term natural history of geographic atrophy from age-related macular degeneration: Enlargement of atrophy and implications for interventional clinical trials
    • Sunness JS, Margalit E, Srikumaran D, et al. The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology. 2007;114(2):271-277.
    • (2007) Ophthalmology. , vol.114 , Issue.2 , pp. 271-277
    • Sunness, J.S.1    Margalit, E.2    Srikumaran, D.3
  • 14
    • 20244380171 scopus 로고    scopus 로고
    • Complement factor H polymorphism in age-related macular degeneration
    • Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5720):385-389.
    • (2005) Science. , vol.308 , Issue.5720 , pp. 385-389
    • Klein, R.J.1    Zeiss, C.2    Chew, E.Y.3
  • 16
    • 77956897697 scopus 로고    scopus 로고
    • Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina
    • Clark SJ, Perveen R, Hakobyan S, et al. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem. 2010; 285(39):30192-30202.
    • (2010) J Biol Chem. , vol.285 , Issue.39 , pp. 30192-30202
    • Clark, S.J.1    Perveen, R.2    Hakobyan, S.3
  • 17
    • 84863338297 scopus 로고    scopus 로고
    • Complement factor H genetic variant and age-related macular degeneration: Effect size, modifiers and relationship to disease subtype
    • Sofat R, Casas JP, Webster AR, et al. Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol. 2012;41(1):250-262.
    • (2012) Int J Epidemiol. , vol.41 , Issue.1 , pp. 250-262
    • Sofat, R.1    Casas, J.P.2    Webster, A.R.3
  • 18
    • 79951813768 scopus 로고    scopus 로고
    • Polymorphisms in ARMS2 (LOC387715) and LOXL1genes in the Japanese with age-related macular degeneration
    • Fuse N, Mengkegale M, Miyazawa A, et al. Polymorphisms in ARMS2 (LOC387715) and LOXL1genes in the Japanese with age-related macular degeneration. Am J Ophthalmol. 151(3):550-556.
    • Am J Ophthalmol. , vol.151 , Issue.3 , pp. 550-556
    • Fuse, N.1    Mengkegale, M.2    Miyazawa, A.3
  • 19
    • 84872236150 scopus 로고    scopus 로고
    • Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy
    • Cheng Y, Huang L, Li X, Zhou P, Zeng W, Zhang C. Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy. PLoS One. 2013;8(1):e53665.
    • (2013) PLoS One. , vol.8 , Issue.1
    • Cheng, Y.1    Huang, L.2    Li, X.3    Zhou, P.4    Zeng, W.5    Zhang, C.6
  • 20
    • 84918832066 scopus 로고    scopus 로고
    • Retina and vitreous
    • American Academy of Ophthalmology
    • Schubert HD, et al. Retina and vitreous. In: Basic and Clinical Science Course. American Academy of Ophthalmology, 2013-2014:64.
    • (2013) Basic and Clinical Science Course. , pp. 64
    • Schubert, H.D.1
  • 21
    • 84934760290 scopus 로고    scopus 로고
    • ed. Thomas E Andreoli et al. Philadelphia: Saunders
    • Andreoli TE. Cecil's Essentials of Medicine, ed. Thomas E Andreoli et al. Philadelphia: Saunders, 2004:804-807.
    • (2004) Cecil's Essentials of Medicine , pp. 804-807
    • Andreoli, T.E.1
  • 22
    • 0034012166 scopus 로고    scopus 로고
    • Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease
    • Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14(7):835-846.
    • (2000) FASEB J. , vol.14 , Issue.7 , pp. 835-846
    • Mullins, R.F.1    Russell, S.R.2    Anderson, D.H.3    Hageman, G.S.4
  • 23
    • 79952454215 scopus 로고    scopus 로고
    • The significance of the complement system for the pathogenesis of age-rTlated macular degeneration - current evidence and translation into clinical application
    • Charbel Issa P, Chong NV, Scholl HP. The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol. 2011;249(2):163-174.
    • (2011) Graefes Arch Clin Exp Ophthalmol. , vol.249 , Issue.2 , pp. 163-174
    • Charbel Issa, P.1    Chong, N.V.2    Scholl, H.P.3
  • 24
    • 84900433175 scopus 로고    scopus 로고
    • Growth of geographic atropy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration
    • Caire J, Recalde S, Velazquez-Villoria A, et al. Growth of geographic atropy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration. JAMA Ophthalmol. 2014;132(5):528-534.
    • (2014) JAMA Ophthalmol. , vol.132 , Issue.5 , pp. 528-534
    • Caire, J.1    Recalde, S.2    Velazquez-Villoria, A.3
  • 25
    • 84899540510 scopus 로고    scopus 로고
    • The role of the complement system in age-related macular degeneration
    • Weber BH, Charbel Issa P, Pauly D, et al. The role of the complement system in age-related macular degeneration. Dtsch Arztebl Int. 2014; 111(8):133-138.
    • (2014) Dtsch Arztebl Int. , vol.111 , Issue.8 , pp. 133-138
    • Weber, B.H.1    Charbel Issa, P.2    Pauly, D.3
  • 28
    • 84895075477 scopus 로고    scopus 로고
    • A phase ia dose-escalation study of the anti-factor D monoclonal antibody fragment FCFD4514S in patients with geographic atrophy
    • Do DV, Pieramici DJ, van Lookeren Campagne M, et al; Phase Ia Investigators. A phase ia dose-escalation study of the anti-factor D monoclonal antibody fragment FCFD4514S in patients with geographic atrophy. Retina. 2014;34(2):313-320.
    • (2014) Retina. , vol.34 , Issue.2 , pp. 313-320
    • Do, D.V.1    Pieramici, D.J.2    van Lookeren Campagne, M.3    Phase Ia Investigators4
  • 29
    • 0029935480 scopus 로고    scopus 로고
    • Complement factor D, a novel serine protease
    • Volanakis JE, Narayana SV. Complement factor D, a novel serine protease. Protein Sci. 1996;5(4):553-564.
    • (1996) Protein Sci. , vol.5 , Issue.4 , pp. 553-564
    • Volanakis, J.E.1    Narayana, S.V.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.